UBS Group’s Intensity Therapeutics INTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84K | Buy |
9,234
+6,137
| +198% | +$1.88K | ﹤0.01% | 8095 |
|
|
2025
Q1 | $6.1K | Buy |
3,097
+76
| +3% | +$150 | ﹤0.01% | 7616 |
|
|
2024
Q4 | $5.32K | Sell |
3,021
-17,588
| -85% | -$31K | ﹤0.01% | 7436 |
|
|
2024
Q3 | $78.7K | Buy |
20,609
+17,293
| +522% | +$66.1K | ﹤0.01% | 5332 |
|
|
2024
Q2 | $16.2K | Buy |
3,316
+305
| +10% | +$1.49K | ﹤0.01% | 6287 |
|
|
2024
Q1 | $15.7K | Buy |
3,011
+2,511
| +502% | +$13.1K | ﹤0.01% | 5861 |
|
|
2023
Q4 | $4.29K | Buy |
+500
| New | +$4.29K | ﹤0.01% | 6674 |
|